SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036443
Filing Date
2019-10-04
Accepted
2019-10-04 08:47:53
Documents
12
Period of Report
2019-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20191002.htm   iXBRL 8-K 30618
  Complete submission text file 0001564590-19-036443.txt   160246

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20191002.xsd EX-101.SCH 5969
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20191002_lab.xml EX-101.LAB 19483
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20191002_pre.xml EX-101.PRE 11632
8 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20191002_htm.xml XML 3551
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191137652
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences